NOAC dosing in AF patients post-ACS/PCI (see ‘Patients with atrial fibrillation and coronary artery disease' section)

	Standard dose	Comments/dose reduction
Apixaban244	5 mg BID	Dose reduction as for SPAF
Dabigatran247	150 mg BID or 110 mg BID	110mg as for SPAF403
Edoxaban245	60 mg QD	Dose reduction as for SPAF
Rivaroxaban246	15 mg QD	Dose reduction to 10 mg QD if CrCl 30–49 mL/min

In addition to single/dual antiplatelet therapy, where applicable. See ‘Patients with atrial fibrillation and coronary artery disease' section for details.

BID, twice daily; CrCl, creatinine clearance; QD, once daily; SPAF, stroke prevention in atrial fibrillation.